Bluejay Diagnostics (BJDX) Receivables - Other (2022 - 2025)
Bluejay Diagnostics (BJDX) reported Receivables - Other of $6873.0 for Q1 2025, down 90.66% on a YoY basis from $73591.0 in Q1 2024, and down 52.81% sequentially from $14564.0 in Q4 2024.
Bluejay Diagnostics (BJDX) Receivables - Other (2022 - 2025) Analysis & Trends
Bluejay Diagnostics (BJDX) has 4 years of Receivables - Other data on file, last reported at $6873.0 in Q1 2025.
- For the quarter ending Q1 2025, Receivables - Other fell 90.66% year-over-year to $6873.0; the trailing twelve-month figure through Mar 2025 stood at $6873.0 (down 90.66% YoY), and the FY2024 full-year result was $14564.0, down 64.71% from the prior year.
- Receivables - Other slipped to $6873.0 in Q1 2025, from $14564.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $73591.0 in Q1 2024 to a low of $6873.0 in Q1 2025.
- A 4-year average of $27850.3 and a median of $19731.0 in 2022 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other surged 109.16% in 2023 and tumbled 90.66% in 2025, its largest moves.
- Tracing BJDX's Receivables - Other over 4 years: stood at $19731.0 in 2022, then jumped by 109.16% to $41269.0 in 2023, then sank by 64.71% to $14564.0 in 2024, then sank by 52.81% to $6873.0 in 2025.
- Business Quant data shows BJDX's Receivables - Other at $6873.0 in Q1 2025, $14564.0 in Q4 2024, and $8315.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 6,873.00 |
| Mar 31, 2025 | 6,873.00 |
| Dec 31, 2024 | 14,564.00 |
| Dec 31, 2024 | 14,564.00 |
| Sep 30, 2024 | 8,315.00 |
| Sep 30, 2024 | 8,315.00 |
| Jun 30, 2024 | 30,609.00 |
| Jun 30, 2024 | 30,609.00 |
| Mar 31, 2024 | 73,591.00 |
| Mar 31, 2024 | 73,591.00 |
| Dec 31, 2023 | 41,269.00 |
| Dec 31, 2023 | 41,269.00 |
| Dec 31, 2022 | 19,731.00 |
| Dec 31, 2022 | 19,731.00 |